AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A plain language summary of the 5-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma

Reinhard Dummer,Keith T. Flaherty,Caroline Robert,Ana Arance,Jan Willem B. de Groot,Claus Garbe,Helen J. Gogas,Ralf Gutzmer,Ivana Krajsova,Gabriella Liszkay,Carmen Loquai,Mario Mandala,Dirk Schadendorf,Naoya Yamazaki,Alessandra di Pietro,Jean Cantey-Kiser,Michelle Edwards,Paolo A. Ascierto

FUTURE ONCOLOGY（2023）

引用 0|浏览6
暂无评分
关键词
binimetinib, BRAF inhibitor, BRAF V600, COLUMBUS, COLUMBUS part 1, encorafenib, MEK inhibitor, melanoma, plain language summary, vemurafenib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要